Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Blood (2022) 140 (Supplement 2): LBA-3.

https://doi.org/10.1182/blood-2022-171733

Published: 2022

Journal Articles

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

Blood (2022) 140 (Supplement 1): 1773–1774.

https://doi.org/10.1182/blood-2022-162157

Published: 2022

Journal Articles

Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group

Blood (2022) 140 (Supplement 1): 1501–1503.

https://doi.org/10.1182/blood-2022-169324

Published: 2022

Journal Articles

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M. van Noesel, Jan A. M. van Laar, Robert M. Verdijk, Uta E. Flucke, Pancras C. W. Hogendoorn, F. J. Sherida H. Woei-A-Jin, Raf Sciot, Andreas Beilken, Friedrich Feuerhake, Martin Ebinger, Robert Möhle, Falko Fend, Antje Bornemann, Verena Wiegering, Karen Ernestus, Tina Méry, Olga Gryniewicz-Kwiatkowska, Bozenna Dembowska-Baginska, Dmitry A. Evseev, Vsevolod Potapenko, Vadim V. Baykov, Stefania Gaspari, Sabrina Rossi, Marco Gessi, Gianpiero Tamburrini, Sébastien Héritier, Jean Donadieu, Jacinthe Bonneau-Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Marie-Laure Jullié, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale M. Barbaro, Alysa Poulin, Ingrid S. Tam, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna L. Weinstein, Irem Eldem, Bryan A. Sisk, Vaishnavi Sridhar, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova-Drus, Stephen Z. Peeke, Laura S. Muñoz-Arcos, Daniel G. Leino, David D. Grier, Robert Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, Michael M. Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean-François Emile

Blood (2022) 139 (2): 256–280.

https://doi.org/10.1182/blood.2021013338

Published: 2022

Includes: Supplemental data

Journal Articles

Genomic Landscape and Molecular Risk in Patients with Advanced Myelofibrosis Treated within the Multicenter Phase Ib/II MPNSG0212 (POMINC) Trial

Blood (2021) 138 (Supplement 1): 4637.

https://doi.org/10.1182/blood-2021-150361

Published: 2021

Journal Articles

Updated Results from the German Mpnsg-0212 Combination Trial: Ruxolitinib Plus Pomalidomide in Myelofibrosis with Anemia

Blood (2019) 134 (Supplement_1): 672.

https://doi.org/10.1182/blood-2019-127859

Published: 2019

Journal Articles

Addition of Plerixafor Overcomes Poor Mobilization in Autologous and Allogeneic Stem Cell Grafts and Leads to Efficient and Sustained Engraftment

Sebastian Haen, MD, Irmtraud Schober-Melms, Michael Schumm, DVM, Joerg Henes, Robert Möhle, MD, Wolfgang Bethge, MD, Lothar Kanz, Wichard Vogel

Blood (2017) 130 (Supplement 1): 5457.

https://doi.org/10.1182/blood.V130.Suppl_1.5457.5457

Published: 2017

Journal Articles

Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110)

Blood (2016) 128 (22): 1939.

https://doi.org/10.1182/blood.V128.22.1939.1939

Published: 2016

Journal Articles

High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for Relapsed or Refractory Primary CNS Lymphoma - a Prospective Multicentre Trial By the German Cooperative PCNSL Study Group

Blood (2016) 128 (22): 781.

https://doi.org/10.1182/blood.V128.22.781.781

Published: 2016

Journal Articles

A Phase-Ib/II Study of Ruxolitinib Plus Pomalidomide in Myelofibrosis

Frank Stegelmann, MD, Markus Bangerter, MD, Florian H Heidel, MD, Martin Griesshammer, MD, Holger Hebart, MD, Andreas Hochhaus, MD, Steffen Koschmieder, MD, Robert Möhle, MD, Andreas Reiter, MD, Christof Scheid, MD PhD, Rebecca Kirschbaum, Regina Reim, Ulrike Sutter, Katrin Vetter, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD

Blood (2015) 126 (23): 826.

https://doi.org/10.1182/blood.V126.23.826.826

Published: 2015

Journal Articles

High Dose-Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation for Patients with Refractory or Recurrent Primary Central Nervous System Lymphoma –Results of a Multicenter Study By the Germany Collaborative PCNSL Study Group

Gerald Illerhaus, MD, Kristina Fritsch, MD, Ingo Schmidt-Wolf, MD, Roland Schroers, MD, Gerlinde Egerer, MD, Agnieszka Korfel, MD, Tobias Birnbaum, MD, Monika Lamprecht, MD, Nikolas von Bubnoff, Hans-Heinrich Wolf, MD, Stephan Stilgenbauer, MD, Martin Trepel, MD PhD, Robert Möhle, MD, Claudia Hader, MD, Gabriele Ihorst, Heidi Fricker, Benjamin Kasenda, MD, Elisabeth Schorb, MD, Jürgen Finke, MD

Blood (2014) 124 (21): 2527.

https://doi.org/10.1182/blood.V124.21.2527.2527

Published: 2014

Journal Articles

Daily G-CSF (filgrastim) and a Single Dose Of Pegylated G-CSF (pegfilgrastim) After Chemotherapy Result In Different Kinetics Of Circulating Hematopoetic Progenitors: Implication For Potential Stem Cell Harvesting

Felix Schaub, Birgit Federmann, MD, Lothar Kanz, MD, Robert Möhle, MD

Blood (2013) 122 (21): 4513.

https://doi.org/10.1182/blood.V122.21.4513.4513

Published: 2013

Journal Articles

Cysteinyl Leukotrienes Signal Via Overexpressed CysLT1, but Not CysLT2 Receptor In Chronic Lymphocytic Leukemia

Adriana Drost, Mirjam Funk, Karoline Norz, Anne Zipfel, Lothar Kanz, Robert Mohle

Blood (2010) 116 (21): 3612.

https://doi.org/10.1182/blood.V116.21.3612.3612

Published: 2010

Journal Articles

Differential Signaling of G Protein-Coupled Chemotactic Receptors (CXCR4, cysLT1 and S1P1) Expressed in Hematopoietic Progenitor Cells.

Xingkui Xue, Andreas Boehmler, Lothar Kanz, Gabriele Seitz, Robert Mohle

Blood (2006) 108 (11): 1342.

https://doi.org/10.1182/blood.V108.11.1342.1342

Published: 2006

Journal Articles

Selective FLT3 Inhibition Uncovers the Role of FL and FLT3 in Normal CD34+ Hematopoietic Stem Cells.

Katja C. Weisel, MD, Sedat Yildirim, M.D., Xingkui Xue, M.D., Lothar Kanz, M.D., Robert Mohle, M.D.

Blood (2006) 108 (11): 1327.

https://doi.org/10.1182/blood.V108.11.1327.1327

Published: 2006

Journal Articles

Prolonged Survival of Chronic Lymphocytic Leukemia Cells Induced by Sphingosine 1-Phosphate Is Mediated by the G Protein-Coupled Receptor S1P1 and Involves Erk/MAP Kinase, but Not Akt Signaling.

Gabriele Seitz, Sedat Yildirim, Andreas Boehmler, Lothar Kanz, Robert Mohle

Blood (2006) 108 (11): 2801.

https://doi.org/10.1182/blood.V108.11.2801.2801

Published: 2006

Journal Articles

The G Protein-Coupled Receptor cysLT1 Is Expressed in Acute Myeloid Leukemia Mediating Cell Migration and Survival.

Christina Rether, Sandra Hengstebeck, Xingkui Xue, Andreas Boehmler, Lothar Kanz, Gabriele Seitz, Robert Mohle

Blood (2006) 108 (11): 1933.

https://doi.org/10.1182/blood.V108.11.1933.1933

Published: 2006

Journal Articles

Stromal Derived Factor-1–Induced Chemokinesis of Cord Blood CD34 + Cells (Long-Term Culture-Initiating Cells) Through Endothelial Cells Is Mediated by E-Selectin

Afzal J. Naiyer, Deog-Yeon Jo, Jongcheol Ahn, Robert Mohle, Mario Peichev, George Lam, Roy L. Silverstein, Malcolm A.S. Moore, Shahin Rafii

Blood (1999) 94 (12): 4011–4019.

https://doi.org/10.1182/blood.V94.12.4011

Published: 1999

Journal Articles

Evidence for Circulating Bone Marrow-Derived Endothelial Cells

Qun Shi, Shahin Rafii, Moses Hong-De Wu, Errol S. Wijelath, Cong Yu, Atsushi Ishida, Yuji Fujita, Sudesh Kothari, Robert Mohle, Lester R. Sauvage, Malcom A.S. Moore, Rainer F. Storb, William P. Hammond

Blood (1998) 92 (2): 362–367.

https://doi.org/10.1182/blood.V92.2.362

Published: 1998

NARROW

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Genomic Landscape and Molecular Risk in Patients with Advanced Myelofibrosis Treated within the Multicenter Phase Ib/II MPNSG0212 (POMINC) Trial

Updated Results from the German Mpnsg-0212 Combination Trial: Ruxolitinib Plus Pomalidomide in Myelofibrosis with Anemia

Addition of Plerixafor Overcomes Poor Mobilization in Autologous and Allogeneic Stem Cell Grafts and Leads to Efficient and Sustained Engraftment

Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110)

High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for Relapsed or Refractory Primary CNS Lymphoma - a Prospective Multicentre Trial By the German Cooperative PCNSL Study Group

A Phase-Ib/II Study of Ruxolitinib Plus Pomalidomide in Myelofibrosis

High Dose-Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation for Patients with Refractory or Recurrent Primary Central Nervous System Lymphoma –Results of a Multicenter Study By the Germany Collaborative PCNSL Study Group

Daily G-CSF (filgrastim) and a Single Dose Of Pegylated G-CSF (pegfilgrastim) After Chemotherapy Result In Different Kinetics Of Circulating Hematopoetic Progenitors: Implication For Potential Stem Cell Harvesting

Cysteinyl Leukotrienes Signal Via Overexpressed CysLT1, but Not CysLT2 Receptor In Chronic Lymphocytic Leukemia

Differential Signaling of G Protein-Coupled Chemotactic Receptors (CXCR4, cysLT1 and S1P1) Expressed in Hematopoietic Progenitor Cells.

Selective FLT3 Inhibition Uncovers the Role of FL and FLT3 in Normal CD34+ Hematopoietic Stem Cells.

Prolonged Survival of Chronic Lymphocytic Leukemia Cells Induced by Sphingosine 1-Phosphate Is Mediated by the G Protein-Coupled Receptor S1P1 and Involves Erk/MAP Kinase, but Not Akt Signaling.

The G Protein-Coupled Receptor cysLT1 Is Expressed in Acute Myeloid Leukemia Mediating Cell Migration and Survival.

Stromal Derived Factor-1–Induced Chemokinesis of Cord Blood CD34 + Cells (Long-Term Culture-Initiating Cells) Through Endothelial Cells Is Mediated by E-Selectin

Evidence for Circulating Bone Marrow-Derived Endothelial Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only